WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004100987) METHODS OF USING IL-1 ANTAGONISTS TO TREAT NEOINTIMAL HYPERPLASIA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/100987    International Application No.:    PCT/US2004/014032
Publication Date: 25.11.2004 International Filing Date: 06.05.2004
Chapter 2 Demand Filed:    03.12.2004    
IPC:
A61K 31/7088 (2006.01), A61K 38/17 (2006.01), A61K 38/20 (2006.01), A61K 39/395 (2006.01), C07K 14/715 (2006.01)
Applicants: REGENERON PHARMACEUTICALS, INC. [US/US]; 777 Old Saw Mill River Road, Tarrytown, NY 10591 (US) (For All Designated States Except US).
WANG, Li-Hsien [--/US]; (US) (For US Only).
LIN, Hsin, Chieh [US/US]; (US) (For US Only).
KAROW, Margaret [US/US]; (US) (For US Only)
Inventors: WANG, Li-Hsien; (US).
LIN, Hsin, Chieh; (US).
KAROW, Margaret; (US)
Agent: GREGG, Valeta; Regeneron Pharmaceuticals, Inc, 777 Old Saw Mill River Road, Tarrytown, NY 10591 (US)
Priority Data:
60/468,232 06.05.2003 US
Title (EN) METHODS OF USING IL-1 ANTAGONISTS TO TREAT NEOINTIMAL HYPERPLASIA
(FR) PROCEDE D'UTILISATION D'ANTAGONISTES DE L'IL1 POUR LE TRAITEMENT D'HYPERPLASIE NEOINTIMALE
Abstract: front page image
(EN)Methods of using interleukin-1 (IL-1) antagonists to prevent or treat restenosis and other neointimal hyperplasia conditions, including atherosclerosis, vascular access dysfunction, hypertension and related vascular diseases are provided.
(FR)La présente invention a trait à des procédés d'utilisation d'antagonistes de l'interleukine-1 (IL1) pour la prévention ou le traitement de la resténose et autres conditions de l'hyperplasie néointimale, comprenant l'athérosclérose, le dysfonctionnement d'accès vasculaire, l'hypertension et des maladies vasculaires associées.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)